We are live on
!
Find out more
P
Paradiem Portfolio holdings
AUM
$464M
1-Year Est. Return
45.56%
This Fund
S&P 500
This Quarter
Est. Return
+9.33%
1 Year Est. Return
+45.56%
3 Year Est. Return
+107.16%
5 Year Est. Return
+136.03%
10 Year Est. Return
–
AUM
$322M
AUM Growth
+$51.5M
(+19%)
Cap. Flow
+$29.9M
Cap. Flow
% of AUM
9.3%
Top 10 Holdings %
Top 10 Hldgs %
19.57%
Holding
103
New
9
Increased
51
Reduced
34
Closed
3
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
CPRX
Catalyst Pharmaceutical
CPRX
|
+$3.9M |
| 2 |
IBMM
iShares iBonds Dec 2024 Term Muni Bond ETF
IBMM
|
+$3.24M |
| 3 |
Matsons
MATX
|
+$2.59M |
| 4 |
Fabrinet
FN
|
+$2.57M |
| 5 |
BSCP
Invesco BulletShares 2025 Corporate Bond ETF
BSCP
|
+$2.23M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Inspire 100 ETF
BIBL
|
+$3.78M |
| 2 |
PENG
Penguin Solutions Inc
PENG
|
+$2.9M |
| 3 |
Entegris
ENTG
|
+$1.74M |
| 4 |
Caterpillar
CAT
|
+$877K |
| 5 |
NVIDIA
NVDA
|
+$854K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 28.93% |
| 2 | Industrials | 17.3% |
| 3 | Materials | 9.45% |
| 4 | Healthcare | 8.79% |
| 5 | Financials | 6.42% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
101
Elbit Systems
ESLT
$37.9B
| – | – |
-2,183
| Closed | -$358K |
|
|
PENG
102
Penguin Solutions Inc
PENG
$2.7B
| – | – |
-194,963
| Closed | -$2.9M |
|
Similar funds
DF
FNBTCON
RAA
CWWM
HSA
CPIM
SHWM
ACGA
Paradiem's Q1 2023 Portfolio in Review
As of Q1 2023, Paradiem held 103 positions worth $322M, up 19% from $271M the previous quarter. Its ten largest holdings account for 20% of the portfolio.
Paradiem deployed $29.9M of net new capital in Q1 2023, opening 9 new positions and adding to 51 existing holdings. Its largest new stake was Catalyst Pharmaceutical: 236,628 shares worth $3.92M.
By sector, the portfolio is most concentrated in Technology at 29% of assets, down from 31% a quarter earlier, followed by Industrials and Materials.
On the sell side, the largest reduction was Inspire 100 ETF, an estimated $3.78M trimmed.
- Paradiem's largest Q1 2023 buy was Catalyst Pharmaceutical: 236,628 shares worth $3.92M.
- Paradiem added most to Matsons in Q1 2023, an estimated $2.59M increase.
- Paradiem's biggest Q1 2023 reduction was Inspire 100 ETF, cutting an estimated $3.78M.
- Paradiem fully exited Penguin Solutions Inc in Q1 2023, selling an estimated $2.9M.
- Paradiem's ten largest holdings make up 20% of its $322M portfolio in Q1 2023.
- Paradiem opened 9 new positions and closed 3 in Q1 2023.
- Paradiem's portfolio value rose 19% quarter-over-quarter to $322M.
Based on Paradiem's 13F filing for Q1 2023, filed 10 Apr 2023.